GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Acadia Pharmaceuticals Inc. (ACAD) [hlAlert]

Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders. The Company is developing a portfolio consisting of its four product candidates, including
pimavanserin, which is in Phase III development for the treatment of Parkinson?s disease psychosis. In addition, the Company has a product candidate in Phase II for chronic pain and a product candidate in Phase I for glaucoma, both in collaboration with Allergan, Inc., and ACP-106 in IND-track development. The Company?s product candidates include Pimavanserin, AGN-XX/YY, AC-262271 and ACP-106. The Company maintains two wholly owned subsidiaries: ACADIA Pharmaceuticals AB based in Malmo, Sweden and ACADIA Pharmaceuticals A/S based in Denmark.
.
( Total: 15 Current Stock Recommendations )
Acadia Pharmaceuticals Inc.   (15)
Sell Hold 33% Buy 53%
Related companies
China Biologic ...   (4)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Talecris ...   (4)
Buy 100%
Anacor ...   (6)
Buy 100%
Santarus, Inc.   (13)
Hold 31% Buy 69%
Cardinal Health, ...   (24)
Hold 29% Buy 71%
Incyte Corporation   (22)
Sell Hold Buy 82%
Nbty, Inc.   (9)
Hold 44% Buy 56%
Dr. Reddy's ...   (5)
Sell 20% Hold 40% Buy 40%
Salix ...   (31)
Hold 39% Buy 61%
Filter by Gains:   
  
Rating:
Buy ACAD
up 589.27 %

Rating:
Buy ACAD
up 15.36 %

Rating:
Buy ACAD
up 589.27 %

Rating:
Buy ACAD
up 2,299.36 %

Rating:
Hold ACAD
up 61.00 %

Rating:
Buy ACAD
up 589.27 %

Rating:
Buy ACAD
up 61.00 %

Rating:
Buy ACAD
up 2,299.36 %

Rating:
Buy ACAD
up 589.27 %

Rating:
Buy ACAD
up 484.12 %
Acadia Pharmaceuticals Inc. (ACAD) rated Buy by Jefferies
Tuesday,  Mar 19, 2013  8:25 AM ET

Rating:
Buy ACAD
up 2,299.36 %

Rating:
Hold ACAD

Rating:
Buy ACAD
up 664.31 %

Rating:
Buy ACAD
up 2,299.36 %

Rating:
Buy ACAD
up 589.27 %

Your Recent Stocks
SymbolLastChange
ACAD 27.36 down  -27.82 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy